✦ LIBER ✦

The US FDA and animal cloning: Risk and regulatory approach

✍ Scribed by Larisa Rudenko; John C. Matheson

Book ID: 116911094
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 157 KB
Volume: 67
Category: Article
ISSN: 0093-691X
DOI: 10.1016/j.theriogenology.2006.09.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk assessment and the credibility of f

Risk assessment and the credibility of federal regulatory policy: An FDA perspective

✍ Lowe, Mary Frances 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Finding, evaluating, and managing drug-r

Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)

✍ Joyce Weaver; Lois La Grenade; Hyon Kwon; Mark Avigan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Implementation of the FDA regulatory app

Implementation of the FDA regulatory approach to cells and tissue: Focus on cord blood

✍ E. Lazarus 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

In silico toxicology: Predictive methods

In silico toxicology: Predictive methods and applied regulatory research at the US FDA Center for Drug Evaluation and Research

✍ L. Valerio Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Antipsychotics and Torsadogenic Risk: Si

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

✍ Elisabetta Poluzzi, Emanuel Raschi, Ariola Koci, Ugo Moretti, Edoardo Spina… 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 302 KB

Bioequivalence of Highly Variable Drugs:

Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA

✍ Vangelis Karalis; Mira Symillides; Panos Macheras 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 542 KB